Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $4.45B | +$144M | 83 | 0.08% | Increased |
|
| 2 |
Vanguard Group
Malvern,
Pennsylvania
| $4B | +$62.1M | 80 | 0.06% | Increased |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $2.92B | +$436M | 63 | 0.16% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $1.84B | +$69.7M | 76 | 0.07% | Increased |
|
| 5 |
Dimensional Fund Advisors
Austin,
Texas
| $1.53B | +$59.4M | 34 | 0.35% | Increased |
|
| 6 |
Morgan Stanley
New York
| $1.52B | +$9.94M | 91 | 0.1% | Increased |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $1.35B | -$378M | 20 | 0.25% | Reduced |
|
| 8 |
Primecap Management
Pasadena,
California
| $1.34B | -$9.07M | 5 | 1.06% | Reduced |
|
| 9 |
Dodge & Cox
San Francisco,
California
| $1.29B | -$132M | 1 | 0.72% | Reduced |
|
| 10 |
Bank of America
Charlotte,
North Carolina
| $1.05B | +$75.5M | 93 | 0.08% | Increased |
|
| 11 |
Geode Capital Management
Boston,
Massachusetts
| $1.03B | +$41.7M | 88 | 0.07% | Increased |
|
| 12 |
Janus Henderson Group
London,
| $1.03B | -$109M | 19 | 0.5% | Reduced |
|
| 13 |
GS
Gilead Sciences
Foster City,
California
| $924M | $0 | 4 | 72.19% | Maintained |
|
| 14 |
Fisher Asset Management
Camas,
Washington
| $876M | +$1.05M | 4 | 0.35% | Increased |
|
| 15 |
SVGI
Sozo Ventures GP II
Redwood City,
California
| $861M | $0 | 1 | 100% | Maintained |
|
| 16 |
Goldman Sachs
New York
| $836M | -$115M | 63 | 0.11% | Reduced |
|
| 17 |
Viking Global Investors
Stamford,
Connecticut
| $801M | -$127M | 1 | 2.32% | Reduced |
|
| 18 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $781M | +$5.33M | 4 | 0.98% | Increased |
|
| 19 |
Franklin Resources
San Mateo,
California
| $765M | -$122M | 26 | 0.2% | Reduced |
|
| 20 |
UBS Group
Zurich,
Switzerland
| $725M | -$272M | 91 | 0.13% | Reduced |
|
| 21 |
RTW Investments
New York
| $676M | +$26.1M | 8 | 9.63% | Increased |
|
| 22 |
Northern Trust
Chicago,
Illinois
| $656M | +$11.7M | 76 | 0.09% | Increased |
|
| 23 |
ARK Investment Management
St. Petersburg,
Florida
| $623M | -$469K | 3 | 4.57% | Reduced |
|
| 24 |
Kohlberg Kravis Roberts & Co
New York
| $573M | -$218M | 1 | 11.83% | Reduced |
|
| 25 |
Invesco
Atlanta,
Georgia
| $567M | -$115M | 37 | 0.1% | Reduced |
|